Bill Detail
H.R. 11045
Congress: 119
Title
To amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.
Summary
No summary is available in Pulse’s cached record. Check Congress.gov for the official summary.
Sponsor
Rep. Josh Gottheimer [D-NJ-5]
Status
Referred to the House Committee on Energy and Commerce.
Status as of Nov 18, 2026, 4:34 AM · synced 9h ago
Introduced
2026-11-17
Data source mode: cache
Bill Engagement
To amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl,…
Limited preview · paid intelligence
Keep the intelligence current—not just this one record.
Pulse currently has no matching linked lobbying filings for this bill and Congress. Federal Intelligence provides the broader research platform; purchasing access does not guarantee missing records or a bespoke bill watch.
Federal Intelligence is $2,500 one-time for three months, or $9,000 for twelve months prepaid, for one named user. Full tracked federal calendar, connected organization/bill/disclosure research, and a private workspace. Fixed terms; no automatic renewal. No demo or scope email is required for standard access.
SEE A FINISHED HEALTHCARE EXAMPLE
Three days of Hill visits. Two Medicare access questions.
A separate, source-linked editorial example—not a dossier about this bill, an endorsement, or a claim of participation. The full records stay paid.
Read the finished healthcare brief →After verified successful payment, access is activated within one business day and a secure setup link is emailed. Your term starts at activation. These links do not charge you or unlock records. A free alert subscription does not grant full access.